UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE...
WINNIPEG, MANITOBA (AMEX: MCU) today announced that its Board of Directors has unanimously decided to submit a written notice to the American...
WINNIPEG, MANITOBA (AMEX: MCU), a cardiovascular-focused biopharmaceutical company, today announced the appointment of Dwayne Henley as its new...
WINNIPEG, MANITOBA (AMEX: MCU), a cardiovascular-focused biopharmaceutical company, today announced it received a letter from the American Stock...
WINNIPEG, MANITOBA (AMEX: MCU), a cardiovascular-focused biopharmaceutical company, today announced that the positive results from the Phase II...
WINNIPEG, MANITOBA (AMEX: MCU), a cardiovascular-focused biopharmaceutical company, today reported the results of operations for the three and...
WINNIPEG, MANITOBA (AMEX: MCU), a cardiovascular-focused biopharmaceutical company, today commented on the positive results of two large...
WINNIPEG, MANITOBA (AMEX: MCU), a cardiovascular-focused biopharmaceutical company, today announced the presentation of its Phase 3 MEND-CABG II...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.